Xuanzhu Biopharmaceutical Co., Ltd. (HKG:2575)
Hong Kong · Delayed Price · Currency is HKD 63.65
-1.35 (-2.08%)
Jan 21, 2026, 1:24 PM HKT
Xuanzhu Biopharmaceutical Market Cap
Xuanzhu Biopharmaceutical has a market cap or net worth of 33.67 billion as of January 20, 2026.
Market Cap
33.67B
Enterprise Value
33.55B
Revenue
35.02M
Ranking
n/a
PE Ratio
n/a
Stock Price
63.65
Market Cap Chart
Since October 15, 2025, Xuanzhu Biopharmaceutical's market cap has increased from 13.62B to 33.67B, an increase of 147.15%. That is a compound annual growth rate of 2,910.61%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 20, 2026 | 33.67B | -7.80% |
| Dec 31, 2025 | 36.52B | 168.06% |
| Oct 15, 2025 | 13.62B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| China Medical System Holdings | 33.06B |
| Simcere Pharmaceutical Group | 30.59B |
| China Resources Pharmaceutical Group | 28.33B |
| Grand Pharmaceutical Group | 27.07B |
| OneRobotics (Shenzhen) | 25.36B |
| Sunshine Lake Pharma | 24.42B |
| The United Laboratories International Holdings | 22.85B |
| Ab&B Bio-Tech CO., LTD. JS | 18.79B |